Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Epigenetic Therapy: What Is It, Where Are We, and What Does the Future Hold?

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Epigenetic Therapy: What Is It, Where Are We, and What Does the Future Hold?
Targeting aberrant gene silencing in cancer
Jean-Pierre J. Issa
Fels Inst. for Cancer Research & Molecular Biology, Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Epigenetic Therapy: What Is It, Where Are We, and What Does the Future Hold?
Lysine specific demethylase-1 (LSD-1) inhibitors for treatment of cancer
Sunil Sharma
Univ. of Utah Huntsman Cancer Inst., Salt Lake City, UT, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Epigenetic Therapy: What Is It, Where Are We, and What Does the Future Hold?
  •  
  • Permission not
    granted for presentation
  •  
  •  
Genomic and epigenomic mechanisms utilized by mutant p53
Shelley L. Berger
Univ. of Pennsylvania School of Medicine, Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3